课题基金 / 基金详情

项目摘要

项目成果

Michael D Henry的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Description (provided by applicant): Interactions between epithelial cells and the extracellular matrix are critical for the normal development and maintenance of urologic tissues such as the prostate. Our long term objective is to understand how disruption of these interactions contributes to prostate cancer. We have been focused on the role of dystroglycan, an extracellular matrix receptor expressed on prostate epithelial cells which we have implicated in prostate cancer, as a key mediator of interactions with the extracellular matrix. Using a conditional knockout strategy in the mouse, we have identified a novel role for dystroglycan in regulating cell proliferation in the prostate. Here we propose studies to elucidate the role of dystroglycan in prostate epithelial cell proliferation and how this may be related to the normal function of the prostate, including stem/progenitor cell-mediated renewal of this tissue. Accordingly, we have proposed the following specific aims: 1) Define the role of dystroglycan in tissue organization and function of the mouse prostate. Using age-matched cohorts of dystroglycan-mutant and control mice, we will analyze prostate cellular composition, proliferation and cell death in mice 1-18 months old. Additionally, we will analyze the structure of basement membranes and secretory function in these mice. 2) Analyze the role of dystroglycan in regeneration of the mouse prostate. We will determine whether dystroglycan is required for regeneration of the mouse prostate after androgen withdrawal, co-expressed with markers of prostate stem/progenitor cells and located on cells in the proximal prostatic ducts, a putative stem cell niche. The successful completion of these studies will elucidate a role for dystroglycan in regulating cell proliferation of the prostate epithelium and indicate a role for dystroglycan in prostate stem/progenitor cell function. By understanding for the first time the role(s) that dystroglycan plays in the normal prostate, we can further understand how dystroglycan is involved in the urologic malignancy of prostate cancer. Interactions between epithelial cells and their extracellular matrix environment are critical for proper organization, function and homeostasis of the prostate. Here we will investigate the role of dystroglycan, an extracellular matrix receptor present on prostate epithelial cells, in these processes. This work is relevant to understanding how disruption of the normal biology if the prostate lead to diseases such as prostate cancer.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate.
维持小鼠前列腺管腔上皮基底膜或细胞极性不需要肌营养不良聚糖。
DOI: 10.1002/pros.21110
发表时间: 2010
期刊: The Prostate
影响因子: --
作者: [Esser,AlisonK, Cohen,MichaelB, Henry,MichaelD]
通讯作者: Henry,MichaelD
Influence of hemodynamic shear stress on circulating tumor cells
  • 批准号:
    10442218
  • 项目类别:
  • 资助金额:
    $37.37万
  • 财政年份:
    2022
  • 负责人:
    Michael D Henry
  • 依托单位:
Influence of hemodynamic shear stress on circulating tumor cells
  • 批准号:
    10573281
  • 项目类别:
  • 资助金额:
    $35.91万
  • 财政年份:
    2022
  • 负责人:
    Michael D Henry
  • 依托单位:
Improved detection of bladder cancer recurrence using a biophysical biomarker
  • 批准号:
    9988591
  • 项目类别:
  • 资助金额:
    $0.2万
  • 财政年份:
    2017
  • 负责人:
    Michael D Henry
  • 依托单位:
Effects of fluid shear stress on circulating tumor cells
  • 批准号:
    9111247
  • 项目类别:
  • 资助金额:
    $19.84万
  • 财政年份:
    2016
  • 负责人:
    Michael D Henry
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: